StartUp Health July 23, 2024
Nicole Kinsey

This week’s health innovation funding highlights advancements in AI-powered solutions, improving patient access to care, expanding at-home healthcare options, enhancing patient engagement and privacy, and more.

This week’s reported health innovation funding included:

CytoReason, a Tel Aviv, Israel-based developer of computational disease models for predictive insights, raised $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. source>

Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M led by Wittington Ventures and Great Point Ventures, with participation from DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures. source>

Brenig Therapeutics, a Dover, DE-based neurology-focused drug development company utilizing an AI/ML-based discovery platform, raised $65M led by NEA, with participation from OrbiMed, Torrey Pines Investments....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Digital Health, Investments, Technology, Trends
Related Articles:
Salesforce pledges to invest $1 billion in Singapore over five years in AI push
Norm Ai Raises $48 Million to Develop Regulatory AI Agents
The Rise Of The One-Person Unicorn: How AI Agents Are Redefining Entrepreneurship
Sola Raises $30 Million for ‘Self-Serve’ Cybersecurity Solution
AI, Pediatrics, and Clinical Tools Lead This Week’s Global Funding | StartUp Health Insights: Week of Mar 11, 2025

Share This Article